Navigation Links
Yoga Along with Treatment for Breast Cancer Improves Quality of Life

Researchers have found a remarkable improvement in patients who undergo yoga program along with the treatment for breast cancer thereby proving the age-old belief about the interrelation between the mind and the body//. There was a considerable improvement in the quality of life of the patients who participated in the yoga program than those who do not.

The study, presented today at the 42nd annual meeting of the American Society of Clinical Oncology by Lorenzo Cohen, Ph.D., associate professor and director of the Integrative Medicine Program at M. D. Anderson, is one of the first to incorporate yoga as part of a treatment plan for cancer patients. It's also the first collaborative research effort representing the partnership between M. D. Anderson and India's largest yoga research institution, Swami Vivekananda Yoga Anusandhana Samsthana (research foundation) in Bangalore, India.

'Cancer and its treatments are associated with considerable distress, impaired quality of life and reduced physical function. This is particularly true for women with breast cancer who receive multi-modality treatment over an extended period of time,' Cohen says. 'With our studies, we think that we could help ameliorate the treatment-related side effects that accumulate in cancer patients over time.

'The main objective of this study was to examine the feasibility of integrating a daily yoga program into the treatment care plan for women with breast cancer undergoing radiation treatment, and determine if this is something the patients found useful and enjoyable, as well as assessing aspects of their quality of life,' he continued.

Sixty-one women with breast cancer undergoing radiation were randomized to participate in the yoga classes twice weekly at, or around, the time of their radiation appointments, or, as the control group, to be offered yoga post-treatment. The patients ranged from Stage 0 to Stage 3 disease; 48 percent had undergone bre
'"/>




Page: 1 2 3

Related medicine news :

1. Boys Join the Race Along With Girl to Get a Stick like Figure
2. Postmen to Deliver Anti-malaria Medicines Along with Letters in Jharkhand
3. FDA Approval for Lung Cancer Treatment -Avastin Along with Chemotherapy
4. Tooth Decay Bacteria Evolved Along With Man
5. Worlds Oldest High-wire Artiste Hums Along at 98
6. Advances in Treatment of Cataracts
7. Recommendations for Treatment of Blood Pressue
8. Treatment for Menieres disease
9. Treatment for pre-menstrual syndrome is ineffective
10. Better Treatment for obesity
11. Gene Treatment for Heart Disease
Post Your Comments:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 1GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 2GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 3GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 4GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 5GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 6nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 6632 1nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 6632 2MedQuist Integrates Search Engine from Primordial with SpeechQ 28TM 29 for Radiology 6630 1MedQuist Integrates Search Engine from Primordial with SpeechQ 28TM 29 for Radiology 6630 2